Search results
Can Strata Critical Medical, Inc. (SRTA) Run Higher on Rising Earnings Estimates?
Strata Critical Medical, Inc. (SRTA) appears an attractive pick given a noticeable improvement in the company's earnings outlook. The stock has been a strong performer lately, and the momentum might
Can Acadia (ACAD) Run Higher on Rising Earnings Estimates?
Acadia Pharmaceuticals (ACAD) appears an attractive pick given a noticeable improvement in the company's earnings outlook. The stock has been a strong performer lately, and the momentum might
Can HireQuest (HQI) Keep the Earnings Surprise Streak Alive?
If you are looking for a stock that has a solid history of beating earnings estimates and is in a good position to maintain the trend in its next quarterly report, you should consider HireQuest
Fiserv Q2 Earnings Call Highlights
Key Points
- Interested in Fiserv, Inc.? Here are five stocks we like better.
- Fiserv lowered its full-year outlook, now expecting organic revenue growth of negative 1% to flat, adjusted revenue to
EZCORP Q3 Earnings Call Highlights
Key Points
- Interested in EZCORP, Inc.? Here are five stocks we like better.
- Strong quarterly growth: Revenue rose 31% to $408.4 million, adjusted EBITDA increased 48% to $65.6 million, and
Evergy Q2 Earnings Call Highlights
Key Points
- Interested in Evergy Inc.? Here are five stocks we like better.
- Q2 earnings rose: Evergy reported adjusted earnings of $209 million, or $0.88 per share, up from $0.82 a year earlier
Establishment Labs Q2 Earnings Call Highlights
Key Points
- Interested in Establishment Labs Holdings Inc.? Here are five stocks we like better.
- Strong growth and raised outlook: Second-quarter revenue rose 31.7% year over year to $67.5
EuroDry Q2 Earnings Call Highlights
Key Points
- Interested in EuroDry? Here are five stocks we like better.
- EuroDry returned to profitability in Q2 2026 as net revenue rose 57% year over year to $17.7 million and net income
DXP Enterprises Q2 Earnings Call Highlights
Key Points
- Interested in DXP Enterprises, Inc.? Here are five stocks we like better.
- DXP Enterprises delivered strong Q2 growth: Sales rose 15.6% year over year to $576.5 million, while net
ATN International Q2 Earnings Call Highlights
Key Points
- Interested in ATN International, Inc.? Here are five stocks we like better.
- Q2 results improved: Revenue rose 2% year over year to $184.5 million, while adjusted EBITDA increased
ProFrac Q2 Earnings Call Highlights
Key Points
- Interested in ProFrac Holding Corp.? Here are five stocks we like better.
- Second-quarter results improved: Revenue rose to $498 million from $450 million sequentially, while
Pediatrix Medical Tops Q2 Earnings on Better Cash Collections
Pediatrix Medical Group, Inc. MD reported second-quarter 2026 adjusted earnings per share (EPS) of 63 cents, which beat the Zacks Consensus Estimate by 10.5%. The bottom line increased 18.9% year
Can STMicroelectronics Cross $4 Billion Revenues in Q4?
STMicroelectronics N.V. STM appears well positioned to surpass $4 billion in fourth-quarter revenues, supported by accelerating demand across AI infrastructure, automotive and industrial markets
KVUE Q2 Earnings Miss Estimates as Margins Narrows, Sales Rise
Kenvue Inc. KVUE reported second-quarter 2026 results, with both revenues and adjusted earnings increasing from the prior-year period. However, the reported figures came below the Zacks Consensus
CPRI Q1 Earnings Beat Estimates on Margin Gains, Jimmy Choo Growth
Capri Holdings Limited CPRI reported first-quarter fiscal 2027 results, with revenues declining but adjusted earnings increasing year over year. Both metrics surpassed the Zacks Consensus Estimate.
Is EMCOR's Capital Strategy Driving More Than Shareholder Returns?
EMCOR Group, Inc.’s EME second-quarter 2026 financial results offer investors plenty to cheer about beyond another earnings beat. While record revenues, expanding margins and raised guidance grabbed
Is Jacobs Stock a Buy as Strong Growth Meets Execution & Debt Risks?
Jacobs Solutions Inc. J offers a mixed investment case after a quarter marked by faster organic growth, record backlog and wider margins. Demand across infrastructure and advanced facilities
Jacobs Stock Jumps 11.5% in a Month: Can This Rally Keep Running?
Shares of Jacobs Solutions Inc. J gained 11.5% over the past four weeks, drawing attention to whether the advance has more room to run.Record backlog, margin expansion and rising demand tied to
PacBio Q2 Earnings Meet Estimates, Revenues Miss, 2026 Sales View Cut
Pacific Biosciences of California, Inc. PACB, popularly known as PacBio, reported an adjusted loss per share of 14 cents for the second quarter of 2026, wider than the year-ago adjusted loss of 13